Predictive value of NEDA and brain atrophy in MS

 

REPORT FROM ECTRIMS – BARCELONA, SPAIN – OCTOBER 7-10, 2015 – A recent longitudinal study investigated whether MS patients with ongoing disease activity while on treatment had different clinical, radiological and neuropsychological outcomes at one year compared to those with no evidence of disease activity (NEDA), defined as no relapses, no three-month EDSS progression and no new MRI activity (Nygaard et al. PLoS One 2015;10:e0135974; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC4539191/pdf/pone.0135974.pdf).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page